If indeed the rise was strictly due to your article, then I fear we will give these gains back in the short term future.
I think last week's rise was due entirely to the SA article, and I think there is a chance that the buying will continue.
What Chris showed by his article is the potential of a company in a new and intriguing biotechnology field: immunology.
Buyers in the market are composed of traders, speculators, and investors. The traders may soon sell their shares, but the speculators and investors will likely hang on longer. Chris' article may sustain our pps until the next positive news drives it higher.
RCJ
Market Data 
Markets 
AI
